Evidence map›Paper›PMID 33990566›Full record

ArticleNature communications2021

Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments.

Erdem D Tabdanov, Nelson J Rodríguez-Merced, Alexander X Cartagena-Rivera, Vikram V Puram, Mackenzie K Callaway, Ethan A Ensminger, Emily J Pomeroy, Kenta Yamamoto, Walker S Lahr, Beau R Webber and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Immune cells employ intermittent integrin-mediated traction forces for 3D migration.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erdem D Tabdanov *Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA. ekt5171@psu.edu.ORCID 0000-0003-2673-112X
Nelson J Rodríguez-Merced *Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-6778-7819
Alexander X Cartagena-RiveraSection on Mechanobiology, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-6227-2499
Vikram V PuramDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-0764-6053
Mackenzie K CallawayDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-8102-5466
Ethan A EnsmingerDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-2539-3798
Emily J PomeroyMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0001-7690-3570
Kenta YamamotoMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-9424-1993
Walker S LahrMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Beau R WebberMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-3950-8747
Branden S MoriarityMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Alexander S ZhovmerNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Paolo P ProvenzanoDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA. pprovenz@umn.edu.ORCID 0000-0002-9313-1370

Funding

Project 2: Cell Migration in Mechanically Complex MicroenvironmentsU54CA210190 · NCI · UNIVERSITY OF MINNESOTA · PI ODDE, DAVID J. · 2016 to 2020
$10.0M
MechanobiologyZIAEB000094 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI CARTAGENA-RIVERA, ALEXANDER · 2020 to 2025
$6.0M
Stellate cells and their progenitor precursors in pancreas cancer progressionR01CA181385 · NCI · UNIVERSITY OF MINNESOTA · PI PROVENZANO, PAOLO · 2014 to 2018
$1.8M
NCI NIH HHS R01 CA181385NCI NIH HHS U54 CA210190
6 · The paper itself

Abstract

Defining the principles of T cell migration in structurally and mechanically complex tumor microenvironments is critical to understanding escape from antitumor immunity and optimizing T cell-related therapeutic strategies. Here, we engineered nanotextured elastic platforms to study and enhance T cell migration through complex microenvironments and define how the balance between contractility localization-dependent T cell phenotypes influences migration in response to tumor-mimetic structural and mechanical cues. Using these platforms, we characterize a mechanical optimum for migration that can be perturbed by manipulating an axis between microtubule stability and force generation. In 3D environments and live tumors, we demonstrate that microtubule instability, leading to increased Rho pathway-dependent cortical contractility, promotes migration whereas clinically used microtubule-stabilizing chemotherapies profoundly decrease effective migration. We show that rational manipulation of the microtubule-contractility axis, either pharmacologically or through genome engineering, results in engineered T cells that more effectively move through and interrogate 3D matrix and tumor volumes. Thus, engineering cells to better navigate through 3D microenvironments could be part of an effective strategy to enhance efficacy of immune therapeutics.

Indexed as

AnimalsBiomechanical PhenomenaCell MovementCells, CulturedExtracellular MatrixGene Knockout TechniquesGenetic EngineeringHumansMiceMice, TransgenicMicrotubulesModels, BiologicalNanostructuresRho Guanine Nucleotide Exchange FactorsT-LymphocytesTumor EscapeARHGEF2 protein, humanRho Guanine Nucleotide Exchange Factors

Identifiers

PMID33990566
PMCPMC8121808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.